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Abstract: Lack of axon growth ability in the central nervous system poses a
major barrier to achieving functional connectivity after injury. Thus, a nontransgenic regenerative approach to reinnervating targets has important
implications in clinical and research settings. Previous studies using knockout
(KO) mice have demonstrated long distance axon regeneration. Using an
optic nerve injury model, here we evaluate the efficacy of viral, RNAi and
pharmacological approaches that target the PTEN and STAT3 pathways to
improve long distance axon regeneration in wild type (WT) mice. Our data
show that adeno-associated virus (AAV) expressing short hairpin RNA
(shRNA) against PTEN (shPTEN) enhances retinal ganglion cell axon
regeneration after crush injury. However, compared to the previous data in
PTEN KO mice, AAV-shRNA results in a lesser degree of regeneration, likely
due to incomplete gene silencing inherent to RNAi. In comparison, an
extensive enhancement in regeneration is seen when AAV-shPTEN is coupled
to AAV encoding ciliary neurotrophic factor (CNTF) and to a cyclic adenosine
monophosphate (cAMP) analogue, allowing axons to travel long distances and
reach their target. We apply whole tissue imaging that facilitates threedimensional visualization of single regenerating axons and document
heterogeneous terminal patterns in the targets. This shows that some axonal
populations generate extensive arbors and make synapses with the target
neurons. Collectively, we show a combinatorial viral RNAi and
pharmacological strategy that improves long distance regeneration in WT
animals and provide single fiber projection data that indicates a degree of
preservation of target recognition.
Keywords: Axon regeneration, Retinal ganglion cell, PTEN, Axon injury, Axon
guidance

Introduction
Following injury, axons in the adult central nervous system
(CNS) generally fail to regenerate long distances and reinnervate their
target. Using optic nerve injury and conditional knockout (KO) mice,
we and others have previously demonstrated that deleting
phosphatase and tensin homologue (PTEN) and suppressor of cytokine
signaling 3 (SOCS3) in adult retinal ganglion cells (RGC) allows long
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distance optic nerve regeneration and target reinnervation to some
degree 1–3. Moreover, it was reported that PTEN KO combined with
zymosan and cAMP analogue induces long distance regeneration and
partial recovery of visual functions 4, providing a framework for
developing reparative therapy. However, whether non-transgenic
approaches that modulate PTEN alone or with other growth regulating
factors can promote a similar level of RGC axon regeneration in wild
type animals has not been directly addressed. Adeno-associated virus
(AAV) lacks significant pathogenicity and has been used safely in
clinical trials for a number of ocular and non-ocular diseases 5.
Therefore, the first aim of this present study was to evaluate whether
AAV vectors that incorporate RNA interference (RNAi) can suppress
endogenous PTEN in adult RGCs and promote RGC axon regeneration
in the adult mouse. Next, we examined whether combined viral RNAi
and pharmacotherapy approaches that modulate PTEN and other
growth promoters will further improve long distance regeneration of
axons to their brain targets.
On arriving at the final targets, the growth cones of long
projecting axons switch from an extension program to one that
facilitates target recognition and reconnection. One key feature during
this process is the formation of axon arbors that facilitates connection
with their proper target neurons. To visualize single axon and their
entire arbors and to unequivocally assess axon terminals, several
studies in model organisms including zebrafish have used single cell
labeling and whole tissue imaging 6, 7. However, such techniques have
not yet been established for the study of axon targeting in mammals.
In our previous studies, we have described the use of optical clearance
and whole tissue imaging to assess RGC axon regeneration in vivo. In
this present study, we expand the application of these imaging
techniques, establish single axon visualization and determine terminal
morphology of regenerating axons within a visual target in mice.
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Results
Evaluation of AAV2-shRNA mediated PTEN knockdown
and RGC axon regeneration
Here we sought to examine the degree of RGC axon
regeneration after AAV-shRNA mediated PTEN knockdown. To this end,
we first tested a shRNA strategy, based on SIBR vector system 8. In a
SIBR vector, shRNA is located in an intron and flanked by sequences
derived from mir155, an endogenous intronic shRNA. This design
allows a single primary transcript to produce shRNA from intronic
sequences, as well as an intact exon that encodes an enhanced green
fluorescent protein (EGFP) reporter (Figure 1a). Furthermore, this
design allows insertion of four separate shRNA sequences,
concatenated in a single plasmid, each targeting a different region of
PTEN (referred hereafter as “shPTEN4”), thereby increasing the
probability of effectively silencing the gene of interest. Alternatively,
we used a previously tested PTEN targeting sequence 9, 10 shown to be
highly specific to PTEN (referred hereafter as shPTEN1)10. Since AAV
serotype 2 has been shown to effectively transduce postmitotic
neurons including the RGCs 11, these plasmids were then used to
produce adeno-associated virus serotype 2 (AAV-shPTEN4 or
shPTEN1). To evaluate the knockdown efficiency of PTEN, we initially
incubated rat cortical neurons with either AAV-anti-luciferase-EGFP
(AAV-EGFP) or AAV-shPTEN4. Seven days after treatment AAVshPTEN4 markedly suppresses the endogenous expression of PTEN as
shown by immunocytochemistry (Figure 1b; n=2 biological replicates).
To evaluate the gene knockdown efficiency in mouse RGCs, we
injected AAV-shPTEN4 into the vitreous body of young adult C57BL/6
mouse eyes. In cross-section immunohistochemistry performed two
weeks after injection, transduced RGCs show a significant reduction of
PTEN expression compared to control RGCs transduced with AAV-EGFP
(Figure 1c). Flat-mounted retinae show over 90% transduction of
RGCs by the AAV vector (Figure 1d; n=4). Quantification using
western blot in cortical neurons (Figure 1e, f), and PTEN intensity
analysis in retina sections (Figure 1g), we observe about 70%
reduction in PTEN level after AAV-shPTEN4. Consistent with the
previous study 9, 10, AAV-shPTEN containing a single targeting
sequence (AAV-shPTEN1) led to approximately 70% reduction in PTEN
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expression in adult RGCs (data not shown). As an initial test to
examine the effect of PTEN knockdown on RGC axon regeneration, we
injected AAV-shPTEN4, AAV-shPTEN1 or AAV-EGFP two weeks before
an optic nerve crush. Anterograde labeling of regenerating axons by
CTB injection occurred two days prior to sacrifice. As expected, we
observed significant increases in the number of axons growing beyond
the lesion site in mice receiving either AAV-shPTEN4 (6-fold increase)
or AAV-shPTEN1 (4-fold increase) compared to AAV-EGFP treatment at
0.2 mm from the lesion 4 weeks after injury (Figure 2a, b;
n=5/group). We noticed however that the degree of regeneration in
the AAV-shPTEN animals is less extensive than that of the PTEN KO
mice (i.e. PTENf/f mice subjected to AAV-Cre injection) 1. At 4 mm
distal to the lesion (i.e. near the chiasm), we did not observe
regenerating axons in the AAV-shPTEN animals. On the other hand,
more than 20 axons per one optic nerve section were seen at this
distance in the PTEN KO animals treated with AAV-Cre 1. Since we
have previously shown that the level of axotomy-induced cell death is
reduced by PTEN deletion in RGCs 1, we also assessed whether AAVmediated PTEN knockdown will similarly enhance RGC survival. By
using an antibody against βIII tubulin (TUJ1) to immunostain viable
RGCs, we observed that AAV-shPTEN4 treatment results in a 2-fold
increase in RGC survival rates compared to control mice (Figure 2c, d).
Unlike the difference seen in regeneration rate, this increase in
survival is similar to that seen in the PTEN KO mice 1. Overall, these
data demonstrate that PTEN knockdown, albeit at a lower level than
the PTEN KO mice, increases RGC axon regeneration in adult mice.

Figure 1: AAV-shRNA mediated suppression of PTEN
(a) A map of AAV2-shPTEN4 construct. Control and shPTEN constructs contain EGFP
reporter. (b) Immunocytochemistry showing expression of GFP, PTEN, and beta III
tubulin (TUJ1) in cultured cortical neurons incubated with either AAV-anti-luciferaseEGFP (control) or AAV-RNA against PTEN (AAV-shPTEN4) for 7 days. These are
representative micrographs from 2 separate experiments. (c) Retina sections following
control AAV2-EGFP (EGFP) or AAV2-shPTEN4 injection show PTEN knockdown in
ganglion cell layer. (d) Flat-mounted retina 2 weeks following intravitreal injection of
AAV2-shPTEN4, stained with antibodies against GFP and TUJ1 shows >90%
transduction efficiency in RGCs. (e) Western blot of protein lysates extracted from
cultured cortical neurons showing PTEN level at 7 days after the addition of AAVshPTEN4 or AAV-EGFP. (f) Quantification of PTEN level from the western blot. Values
are represented as ratio of PTEN to βIII-tubulin (n=3 biological replicates). (g)
Quantification of PTEN expression in RGCs in retinal sections, measured by ImageJ
densitometry method. Intensity unit is an arbitary value. Error bars, SEM. Scale bars,
20 μm.
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Figure 2: Assessment of RGC axon regeneration following AAV-shRNA
mediated knockdown of PTEN
(a) Representative optic nerve sections of mice receiving AAV2-shPTEN4 or control
AAV2–EGFP injection. Red asterisk, lesion site. (b) Quantification of regenerating
axons in control and shPTEN treated animals (n=5/group) at different distances from
the lesion site. The data are represented as mean number of axons per section. (c)
Representative images of TUJ1 stained wholemount retinae for both groups. (d)
Quantification of RGC density (n=5/group). Error bars, SEM; ****: p<0.0001; ***:
p<0.001, *p<0.05 ANOVA with Bonferroni correction (b) and student’s unpaired t-test
(d). Scale bars, 100 μm (a); 20 μm (b).

Assessment of combinatorial AAV and RNAi strategy to
enhance long distance axon regeneration
PTEN is one of many factors known to regulate RGC axon
regeneration. Other strategies that were shown to facilitate long
distance RGC axon regeneration include deletion of SOCS3 or Klf4, and
elevation of CNTF 2, 12–18. Given the synergistic effects induced by
combining PTEN KO mice with modulation of the CNTF/STAT3
pathway, we sought to test combining RNAi and AAV approach to
target these factors and further improve regeneration. First, we
generated AAV expressing shRNA against SOCS3 using the SIBR
vector system, but this failed to drastically knockdown SOCS3
expression (data not shown). Given that elevation of CNTF using AAV
vector allows significant increase in long distance regeneration in the
injured optic nerve 12–15, 19, we then tested combining AAV-CNTF with
AAV-shPTEN. To mimic clinical situations, all animals in subsequent
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experiments received intravitreal injection immediately after an optic
nerve crush. Consistent with the previous studies, we observed that
animals receiving the AAV expressing a secretable form of CNTF alone
show significant increase in regeneration (Figure 3a, b). Double
combination of AAV-shPTEN with AAV-CNTF did not result in a
significant increase compared to AAV-CNTF alone (Figure 3a, b). Next
we tested the effect of biweekly application of cell permeant cAMP
analogue, cpt-cAMP in improving axon regeneration in the background
of AAV-shPTEN and AAV-CNTF. Previous studies have shown that cptcAMP can facilitate CNS axon regeneration by recruiting multiple
mechanisms including down-regulation of SOCS3 as well as activating
mitogen activated protein kinase (MAPK) and protein kinase A (PKA)
pathways 17, 20. Indeed, this three-way combination of AAV-shPTEN4,
AAV-CNTF and cpt-cAMP (hereafter referred as “PCC” treatment) led to
a marked increase in the number of regenerating axons; there is more
than 3-fold increase in the number of axons regenerating up to 2 mm
distal to the lesion compared to AAV-CNTF alone (Figure 3a, b; n=6–
8/group). Of note, double combination of shPTEN and cpt-cAMP does
not result in an obvious increase in axon regeneration compared to
shPTEN treatment alone (Figure 3b). We also assessed RGC survival
rates in the combinatorial paradigm using TUJ1 immunostaining, and
observed that mice receiving PCC treatment have similar RGC survival
(i.e. over 20% survival compared to the contralateral uninjured retina)
compared to AAV-shPTEN4 and AAV-CNTF/cpt-cAMP-treated groups in
this post-injury treatment paradigm (Figure 3c, d). Overall, these
results show that concomitant modulation of PTEN, CNTF and cAMP
using a combination of viral, RNAi and pharmacotherapy approaches
greatly enhances long distance axon regeneration.
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Figure 3: AAV-shPTEN, AAV-CNTF and cpt-cAMP further improves lengthy RGC
axon regeneration
(a) Representative optic nerve sections of mice receiving various AAV treatments.
Control, AAV2-EGFP; shPTEN4, AAV2-shPTEN4; CNTF, AAV-CNTF; CNTF/cAMP, AAV2CNTF/cpt-cAMP; PCC, AAV2-shPTEN4/AAV2-CNTF/cpt-cAMP. Red asterisk, lesion site.
(a′) Higher-magnification images of the boxed area in A. (b) Quantification of
regenerating axons at different distances from the lesion site (n=6–8/group). *:
p<0.05, Bonferroni test (PCC significantly different to AAV-CNTF and AAV-CNTF/cptcAMP groups). (c) Representative images of TUJ1 stained wholemount retinae from
mice receiving various AAV treatments. (d) Quantification of RGC density
(n=6/group). Error bars, SEM. Scale bars, 100 μm (a); 20 μm (d).

Assessment of RGC axon regeneration in PCC-treated
mouse brains
Next we examined the extent to which the regenerate RGC
axons in PCC-treated animals extend beyond the optic chiasm and
reach their visual targets. To this end, we used tissue clearing and
LSFM to image regenerating axons in whole mouse optic nerves and
brains without the data loss that results from tissue sectioning 21, 22.
This protocol uses THF and BABB to turn optic nerves and brains
relatively transparent (Figure. 4a), allowing visualization of the entire
optic projection in whole tissues (Figure 4b). Animals received crush
injury followed immediately by PCC treatment or AAV-EGFP injection.
By 4 to 6 weeks post-injury, regenerating axons reach the optic
chiasm. About 20% of these axons extend into the opposite, uninjured
optic nerve (Figure. 4c–e). Similar or higher numbers of regenerating
axons are found in the ipsilateral compared to the contralateral optic
tract (Figure 4c–e) en route to more distal visual targets. Similar to
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finding errors are evident in the brain as most axons extend dorsally,
parallel to the third ventricle and do not find the distant brain targets
(i.e. superior colliculus (SC) and lateral geniculate nucleus(LGN)) (data
not shown).

Figure 4: Tissue clearing and ultramicroscopic assessment of axonal
trajectories in the optic chiasm of PCC animals
(a) Adult mouse brains with and without tissue clearing. The eyes and optic nerves are
attached to the brain. (b) Top view of an intact mouse brain. Brain from an uninjured
mouse shows the entire trajectory of CTB-labeled RGC axons: all visual targets are
visible, including the suprachiasmatic nucleus, lateral geniculate nucleus, and superior
colliculus, ipsi- and contralaterally to the injected eye. (c) A horizontal optical slice
from an unsectioned brain of a PCC-treated animal shows CTB-labeled axons in the
optic chiasm. (c′) Higher-magnification of the boxed area in c. (d) Reconstruction of
traced axons through the chiasm. (e) Quantification of axonal trajectories into
different regions in 5 different cases (i.e. ipsi- and contralateral optic tracts,
contralateral optic nerve, and hypothalamic regions). Contra, contralateral; Hypothal.
Hypothalamic region; Ipsi, ipsilateral; IOT, ipsilateral optic tract; LGN, lateral
geniculate nucleus; ON, optic nerve; OT, optic tract; OX, optic chiasm; 3 rd V, 3rd
ventricle; SC, superior coliculus; SCN, suprachiasmatic nucleus. Scale bars, 100 μm.

Characterizing individual axons’ morphologies in a
visual target
Importantly, regenerating axons are found in and around RGCs’
first brain target the suprachiasmatic nucleus (SCN), located directly
above the optic chiasm (Figure 5a). In control animals treated with
AAV-EGFP (n=14), we do not detect any CTB-labeled axons in the
brain (Figure 5b). The growing tips of elongating axons sense their
post-synaptic partners within the target to begin to form arbors and to
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establish synaptic connection. Do the adult RGC axons regenerating
long distances through the optic nerve have the ability to sense their
target and arborize? Traditionally, morphological analysis of axon
terminals and arborization is carried out in histological sections.
However, tissue sections provide limited spatial information, making it
difficult to determine unequivocally whether the axon terminals are in
fact located within a correct region. It is also difficult to ascertain the
extent of arborization, a key step toward establishing a proper target
reconnection. Here, we sought to expand the application of whole
tissue imaging techniques and to evaluate qualitatively the growth
behavior as axons reach a correct visual target, the SCN. To this end,
we scanned individual 2D LSFM images of mouse brains to visualize
CTB-labeled axons. We took advantage of the fact that the number of
axons that reach the SCN is small (ranging between 5 and 40 axons
per animal), allowing us to visualize, trace, and sample single axons
and their entire arbors. The vast majority of PCC treated animals (11
out of 13 mice) had regenerating axons in the SCN. Figure 5 shows
examples of two different animals with regenerating RGC axons
reaching the SCN (Figure 5c, d). We were able to trace all visibly
distinct axons in 2D optical slices and then compile these slices into a
3D reconstruction (Figure 5e–j). In total, we traced 18 axons that
reach the SCN. Overall, we observe at least four different re-growth
patterns in and around the SCN. First, some axons approach the SCN
but turn and bypass the region. Figure 5e shows an example of such
behavior where an axon bifurcates outside the SCN and its branches
extend and wrap around the SCN, suggesting that these axons may be
repelled and actively prevented from entering this nucleus. Second,
some axons enter the SCN, but they traverse and their terminals are
found outside the region (Figure 5f). In this category, axons often
branch within the SCN but the arbors exit and continue to extend
outside the SCN (Figure 5g). Thus, these axons appear to lack signals
that facilitate target recognition. Third, terminals of some axons are
found inside the SCN (Figure 5h). Fourth, there are axons that
generate complex arbors within the target (Figure 5i, j). Figure 5i
shows tracing of such fiber entering the SCN and generating complex
arbors. Immediately after entering the contralateral SCN, this axon
bifurcates and its branches subsequently generate multiple arbors. The
branches stemming from this individual axon extend and cover a large

Gene Therapy, Vol 22, No. 10 (October 2015): pg. 811-821. DOI. This article is © Nature Publishing Group and permission
has been granted for this version to appear in e-Publications@Marquette. Nature Publishing Group does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Nature Publishing Group.

10

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

field area within the SCN, suggesting the possibility that they may
have made synapses with multiple SCN neurons.

Figure 5: Ultramicroscopic visualization of axonal projections in mouse visual
target
(a) Optic chiasm, optic tract and SCN shown by CTB labeling in a cleared, uninjured
brain. (b) Bottom view of a brain containing the SCN (i.e. dotted circles) imaged from
a brain of an injured control mouse subjected to AAV-EGFP injection. None of the
control animals had regenerating axons in the brain. (c) and (d) Bottom view of brains
of two different PCC-treated animals showing regenerated axons in the chiasm and
SCN. Yellow arrowhead indicates a regenerating axon extending into the SCN. Yellow
arrow indicates distal end of the same axon showing continued growth beyond the
SCN. White arrows in d indicate extensive arborization. (e–j), reconstructions of single
axons showing various growth patterns. In (e), an axon bypasses the target. In (f)
and (g), axons traverse the target. In (h), axon terminals are found within the SCN.
In (i) and (j), axons enter the SCN and form complex arborization. ON, optic nerve;
Uninj, uninjured; SCN, suprachiasmatic nucleus. Scale bars, 100 μm.

Synaptogenesis
To find evidence of re-synaptogenesis by regenerated axons, we
performed immunohistochemistry using an antibody against vesicular
glutamate transporter 2 (Vglut2), a major presynaptic protein of RGCs.
We observe that some CTB-labeled axons in the SCN (the anatomical
location depicted in Figure 6a) have Vglut2-positive patches at boutonlike structures and along the axonal length (Figure 6b), suggesting an
accumulation of the molecular machinery characteristic of a
presynaptic terminal. To further confirm the ability of regenerating
axons to make reconnection with the target neurons, we used the
trans-synaptic reporter mouse line, iZ/WAP 24. These transgenic mice
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express a Cre recombinase-inducible WGA under the direction of the
CMV, cytomegalovirus, promoter and serves as a reporter strain, with
successful Cre excision being indicated by WGA expression in Creexpressing neurons. WGA acts as a trans-synaptic tracer, allowing
identification of the synaptic contacts of Cre-expressing neurons 24. In
normal animals, between 40–80% of RGCs expressed WGA at 2 weeks
following intravitreal AAV2-Cre injection as shown by
immunohistochemistry (Figure 6c). In accordance, many WGA+ cells
(i.e. cells that are post-synaptically connected with RGCs) are visible in
the SCN of uninjured animals (Figure 6d). Similarly, WGA+ cells are
present in the LGN in uninjured animals (Figure 6e). In contrast, no
WGA+ cells are detected in injured animals receiving control AAV2EGFP injection (n=5; Figure 6f). In some PCC animals (3 out of 10
animals), we observe WGA+ cells in the SCN in close proximity to CTB+
axons, indicating that these regenerate RGCs reform synapses with the
target (Figure 6g, h). Overall, these data suggest that following the
combinatorial treatment, individual regenerating axons possess
varying capacity to recognize the target, and are able to form
synapses and reconnect with the target neurons.

Figure 6: Regenerate axons following PCC treatment form synapses in the
SCN
(a) Schematic coronal brain section showing the SCN marked in a dotted red
rectangle. (b) CTB-labeled axons (red) in the SCN express presynaptic marker Vglut2
(green). (b′) High-magnifications of the boxed area in (b), with XZ and YZ projections
at the yellow crosshairs. (c) Retinal cross section showing RGCs expressing WGA
(green) six weeks following AAV-Cre injection in iZ/WAP mice. DAPI (blue) is used in
these tissue sections for nuclear staining. (d) WGA+ cells in the SCN of an uninjured
animal. WGA (green) and DAPI (blue). (e) WGA+ cells in the LGN (as marked by
dotted line) of an uninjured animal. WGA (green) and DAPI (blue). (f) No WGA+ cells
are detected in the injured AAV-EGFP control mice (n=5). (g) Low magnification
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coronal brain section showing the SCN of an injured PCC animal, marked in a yellow
circles immunostained with antibodies against WGA. CTB, red; DAPI, blue. (h) High
magnification of the dotted area in (g) showing CTB+ axons (red) wrapping or making
close contact with WGA+ cells in the SCN. Scale bars, 50 μm.

Discussion
Previous studies have demonstrated that RGCs induced to
regenerate in PTEN KO mice travel the entire length of the optic nerve
1
or, in combination with other factors, reach the targets 3, 25 and
induce partial recovery of visual functions 4. While these KO mouse
studies have revealed some key molecular mechanisms underlying
axon regeneration, it remained to be seen whether a non-transgenic
approach that targets PTEN alone or in combination can also promote
a similar degree of optic nerve regeneration and target re-innervation.
Since axonal damage in the optic nerve causes irreversible loss of
visual functions in glaucoma and after trauma, therapeutically relevant
strategies that promote regeneration through the optic nerve and
reconnection have important clinical implications. More broadly,
therapeutic strategies designed to improve RGC axon regeneration
may provide ideas to treat injuries in other long CNS tracts including
the spinal cord.
Previous studies have reported successful uses of nontransgenic PTEN blockers to promote axon regeneration after nerve
injury. Following a spinal cord injury, PTEN antagonist peptide or AAVshPTEN were shown to improve axon regeneration in the spinal cord 9,
26, 27
. Others have demonstrated that PTEN inhibitor
bisperoxovanadium enhances regeneration of sensory axons 28.
However, it has not been established whether AAV-shRNA that
suppresses PTEN would induce regeneration in RGC axons. More
importantly, whether combining RNAi knockdown of PTEN with other
non-transgenic strategies known to increase neuron’s growth ability
could further enhance long distance axon regeneration has not been
directly addressed.
Here we compare rates of RGC axon regeneration following
PTEN knockdown using two AAV vectors each carrying different PTEN
target sequences. Despite protein knockdown efficacy as high as 70–
90%, the effect on axon regeneration is far less robust than that seen
after PTEN deletion in transgenic mice. This difference could be
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attributed to potential off-target effects associated with RNAi (i.e.
silencing of pro-regenerative genes); however, this is unlikely since
the two AAV-shPTEN vectors target different sequences within PTEN.
Furthermore, the shPTEN1 used in this study was previously shown to
cause no detectable off-target effects when the closest potential offtarget genes were examined 10. Thus it is more likely that the weaker
regeneration seen with RNAi is due to incomplete PTEN silencing, a
common limitation in the use of shRNA technology 29. In many
instances, a low level of residual expression may still be sufficient for
gene function. For example, conditional PTEN heterozygote mice
typically display less severe phenotypes than null-homozygotes 30. In
accordance, we observe no obvious increase in axon regeneration after
heterozygous PTEN ablation (i.e. PTENf/+ mice subjected to intravitreal
AAV-Cre injection) (data not shown).
Virally expressed CNTF represents a potent way to induce long
distance RGC axon regeneration. Consistent with the previous studies
12–15, 19
, AAV-CNTF alone results in a significant induction of long
distance regeneration, and cAMP analogue did not significantly
enhance axon regeneration in the background of AAV-CNTF 20, 31.
However, combined treatment of cAMP analogue, AAV-shPTEN, and
AAV-CNTF greatly enhanced regeneration and allowed more axons to
reach the brain. Interestingly, similar enhancement in regeneration
has been reported when PTEN depletion and cAMP analogue are
combined with zymosan 25. Mechanistically, previous studies have
demonstrated that axon regeneration induced by PTEN depletion relies
on downstream activation of Akt/mammalian target of rapamycin
(mTOR). On the other hand, axon regeneration induced by SOCS3
deletion or CNTF elevation is dependent on activation of the signal
transducer and activator of transcription-3 (STAT3) pathway 1–3.
Multiple signaling pathways and molecules have been suggested to
mediate the pro-regenerative effect of cAMP, including activation of
MAPK, PKA and cAMP response element-binding protein (CREB) 17, 20,
32
. It has also been shown that cAMP can reduce CNTF-induced SOCS3
expression, diminishing the effect of this negative feedback system 33.
Thus, it is likely that PCC treatment activates multiple pathways and
mounts complementary growth programs that ultimately lead to more
robust regeneration. However, the intricate mechanisms underlying
the crosstalk between these molecules are unknown and await future
elucidation.
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While mammalian RGCs can be induced to regenerate along the
optic nerve, axons fail to correctly pathfind to their distant targets, the
LGN and SC. These observations are consistent with the notion that
axons do not simply re-use degenerating optic tracts 34. Nonetheless,
some regenerating axons successfully reach a target that is located
much closer to the eye, the SCN. Using whole tissue imaging, we
provide single fiber projection data that unequivocally reveal the
behaviors of regenerating RGC axons as they reach this target. During
development, growing RGC axons navigate towards their targets
where they arborize and form synapses 7, 35, 36. The transition from
axon extension to target recognition and axon branch initiation is
regulated by spatiotemporal expression of receptors and respective
ligands in the axons and target regions. In particular, local expression
of growth factors such as brain derived neurotrophic factor (BDNF) and
fibroblast growth factor 2 (FGF2) have been shown to play critical roles
in modulating axon arborization and synaptic formation in the visual
targets 6, 36, 37. Do adult mammalian brains express relevant target
cues, and do the regenerate RGC axons retain the capacity to
recognize correct targets? These questions have been addressed
extensively using peripheral nerve graft experiments, in which
transected RGC axons are permitted to regenerate through a segment
of peripheral nerve and reinnervate their targets 38–44. These studies
have indicated the presence of considerable axon arborization and
synaptic connection in the SC and concluded that both optic axons and
target neurons in adult mammals retain recognition ability.
In this study, use of single fiber tracing decisively shows
extensive axon arborization, thereby providing morphological evidence
of some axons’ ability to recognize and reconnect with a visual target,
while other axons seem to be repelled from entering this site. Of note,
we observed the presence of synaptic marker (i.e. Vglut2) in a variety
of cases that include animals with relatively high number of axons in
the SCN as well as animals with relatively low axon numbers. Thus, it
is likely that regenerated axons with or without extensive arborization
may make synapses in the SCN. This is further supported in transsynaptic reporter mouse line in which WGA labeled cells were observed
in SCN, indicating that the axons indeed made connection with the
target. Recently, it was reported that axons of pten/socs3 KO animals
make synaptic connections with SCN neurons following pre-chiasmic
lesion 45. However, it is not established whether the PCC in this study
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or the pten/socs3 KO allows restoration of visual functions. Our lab is
currently investigating this question. Since the SCN is normally
innervated by a small population intrinsically photosensitive RGCs
(ipRGCs), a question rises as to whether there is any degree of
neuron-target selectivity in adult animals. While several studies have
used single cell labeling to characterize axon targeting and branching
patterns of different RGC types in lower species such as zebrafish and
Drosophila 7, 37, no such comprehensive data currently exist for
mammals. In this regard, it will be very interesting in the future to
define normal targeting and arborization patterns of individual RGC
types and assess the degree to which regenerating axons recapitulate
this process. In light of different transgenic mouse lines in which
distinct RGC subtypes including ipRGCs are labeled, initiation of such
analysis may be feasible 35, 46.
In summary, our data highlight the limitation of shRNA
technology in fully mimicking KO regeneration phenotypes, and
indicate that combining AAV, shRNA, and pharmacotherapy represents
an alternative and effective strategy to improve axon regeneration and
importantly, target reconnection in WT animals. Further, extended
application of whole brain imaging underscores technical improvement
in conducting a systematic evaluation of axon targeting and uncovers
heterogeneous and distinct terminal patterns by the individual
regenerating axons.

Materials And Methods
Cloning and generation of AAV2-shPTEN, AAV2-Cre and
AAV2-CNTF
To suppress PTEN expression, we adopted a shRNA strategy,
based on SIBR vectors 8 in which shRNA is located in an intron and
flanked by sequences derived from mir155, an endogenous intronic
shRNA. To maximize the probability of effectively targeting PTEN, four
separate shRNA sequences, each targeting a different region of PTEN
were concatenated in a single plasmid, which was then used to
produce adeno-associated virus (AAV-shPTEN). Four sequences that
target both mouse and rat PTEN were designed using siDIRECT
website and design rules 47: four targeted sequences for PTEN are:
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GCAGAAACAAAAGGAGATATCA;GATGATGTTTGAAACTATTCCA;GTAGAG
TTCTTCCACAAACAGA;GATGAAGATCAGCATTCACAAA. Oligonucleotides
encoding hairpin loops that included these sequences and deliberate
mis-matches in the non-target strand were synthesized, annealed,
inserted into the SIBR knockdown vector, and concatenated into a
single plasmid as described 8. A region of the SIBR knockdown vector
comprising the ubiquitin promoter, intronic sequences, knockdown
cassette, and EGFP open reading frame was cloned into an AAVcompatible plasmid (AAV-MCS, Stratagene), from which the CMV
promoter, intron and MCS were removed. SIBR anti-luciferase control
shRNA was transferred to AAV plasmid similarly. To construct AAV
expressing a secretable form of CNTF, an AAV-compatible SIBR vector
was created by PCR-amplifying the knockdown cassette of a SIBR
vector with primers that created 5′ Mlu1
(ACGCGTTTAAACTGGCCTCCGCGCC) and 3′ Cla1
(ccgccgATCGATTCACTTGTACAGCTCGTCCA) sites. This cassette was
inserted into a Stratagene AAV plasmid, replacing the CMV promoter
and B-globin intron. The resulting AAV-SIBR plasmid was then
modified via bridge PCR to create KpnI and BglII sites to flank the
EGFP open reading frame. Plasmid DNA encoding human CNTF was
purchased from OpenBiosystems (Accession: BC068030) and the open
reading frame was amplified using a forward primer that incorporated
both a 5′ Kpn1 restriction site and the NGF signal peptide sequence
(GGTACCATGTCCATGTTGTTCTACACTCTGATCACAGCTTTTCTGATCGGCA
TACAGGCGGCTTTCACAGAGCATTCACCGC) and a reverse primer that
incorporated 3′ BglII site (AGATCTCTACATTTTCTTGTTGTTAGCAA).
PCR-amplified CNTF was then used to replace the EGFP ORF in the
AAV-SIBR vector via standard restriction digest and ligation. All
enzymes were purchased from New England Biolabs. Plasmids were
then used to produce adeno-associated virus serotype-2 (AAV2) (1–
4×1013 particles/ml) at the University of Miami Viral Vector Core. For
making AAV2 expressing Cre recombinase, the cDNA of Cre was
inserted downstream of the CMV promoter/β-globin intron enhancer in
the plasmid pAAV-MCS (Stratagene), containing the AAV2 inverted
terminal repeats and a human growth hormone polyA signal. pAAV-RC
(Stratagene) that encodes the AAV2 genes (rep and cap) and the
helper plasmid (Stratagene) that encodes E2A, E4 and VA were used
for co-transfection in 293T cells to generate recombinant AAV.
Plasmids were then used to produce adeno-associated virus serotype-2
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(AAV2) (1–4×1013 particles/ml) at the University of Miami Viral Vector
Core.

Animals
All animal procedures were performed with the approval of
IACUC at University of Miami. C57BL/6 (male or female; Charles River
Laboratory) mice were used in this study, except for the wheat germ
agglutinin (WGA) experiment in Figure 8 in which iZ/WAP mice
(B6;129-Tg(CMV-Bgeo,-WGA,-ALPP)1Mgmj/J, Jackson Laboratory;
Stock number, 017524)24 were used. The age of animals used at the
start of each experiment was between 4–6 weeks. Animals were
randomly assigned to different treatment groups. The investigator who
analyzed the data was not blinded to the animal identity. The numbers
of animals (n/group) used for each experiment range from 3 up to 14
depending on the type of experiment and are listed in the figure
legends.

Intraorbital optic nerve crush
The optic nerve was exposed intraorbitally and crushed with
jeweler’s forceps (Dumont #5; Roboz) for 10 seconds approximately 1
mm behind the optic disc. To preserve the retinal blood supply, care
was taken not to damage the underlying ophthalmic artery. After the
surgical procedure, mice received a subcutaneous injection of
buprenorphine (0.05 mg/kg, Bedford Lab) as post-operative analgesic.
Eye ointment containing atropine sulphate was applied preoperatively
to protect the cornea during surgery.

Intravitreal injection
For each intravitreal injection, a glass micropipette was inserted
into the temporal eye posterior to the ora serrata and deliberately
angled to avoid lens damage. Approximately 2 μl of vitreal fluid were
withdrawn before injection to accommodate the same volume of either
virus mix or cholera toxin β-subunit (CTB) conjugated with Alexa 555
(Invitrogen). AAV was administered either 2 weeks before or
immediately after crush. cpt-cAMP (8-(4-chlorophenylthio) adenosine3′,5′-cyclic monophosphorothioate; Sigma Aldrich; 50 μM) was
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injected intravitreally on the day of crush and biweekly (i.e. every
other week) thereafter until euthanasia 25. CTB (2 μg/μl) was injected
2–4 days prior to euthanasia. To visualize RGC projection in normal
mice, CTB was injected and animals were euthanized 2–4 days later.
After the completion of eye injection, animals received the same postoperative treatment as described above.

Immunohistochemistry/immunocytochemistry
Animals were perfused transcardially with PBS followed by 4%
paraformaldehyde (PFA) in PBS, then tissues dissected and post-fixed
with 4% PFA in PBS for 1 hour at room temperature. For histological
sectioning, samples were cryoprotected by incubating in 30% sucrose
in PBS for 48 hours. Optic nerves and retinae were cryosectioned to 10
and 20 μm thickness, respectively. Tissue sections were blocked in 5%
normal goat serum and 0.3% Triton X-100 in PBS for 1 hour and
incubated with primary antibodies diluted in blocking buffer overnight
at 4°C, followed by 1 hour incubation with secondary antibodies at
room temperature. For cortical neuron immunocytochemistry, cells
were fixed for 15 minutes in 4% PFA, washed with PBS and stained as
described above. Primary antibodies used were anti-βIII-tubulin
(1:800; Covance; #PRB-435P), PTEN (1:200; CST; #9559S), vesicular
glutamate transporter 2 (Vglut2) (1:500; Synaptic Systems;
#135304), wheat germ agglutinin lectin (WGA) (1:100; Sigma Aldrich;
#T4144-1VL) and GFP (1:1,000; Abcam; #ab13970). All secondary
antibodies (used at dilution of 1:400; Cy2, Cy3 or Cy5) were
purchased from Jackson ImmunoResearch.

Measurement of PTEN immunoreactivity
The mean PTEN staining intensity in RGCs was measured using
ImageJ software. Values for PTEN were based on 8 cells per section, 2
sections per case, and 3 per groups. Only GFP+ cells in the ganglion
cell layer with visible axon projection (i.e. RGCs) were selected for
measurement. As negative controls, we omitted the primary antibody.
Individual mean values were corrected by staining levels in the
corresponding negative controls (i.e. background subtracted) and then
averaged across each group.
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Cortical cell culture
Mixed cortical cultures from P2 rat pups were prepared as
previously described 48. Briefly, cells were dissociated by sequential
digestion in papain (20 U/mL, Worthington) and trypsin (2.5%,
Invitrogen), then cultured in supplemented Neurobasal media
(Invitrogen) in 24-well Falcon plates on a substrate of PDL (100μg/mL,
Sigma) and laminin (100μg/mL, Cultrex) at a density of 50,000 cells
per well. AAV2-shPTEN or AAV2-anti-luciferase (4×108 total particles)
were applied. Cultures were maintained at 37° C in a humidified CO2
incubator for six additional days, with media exchanged every other
day, then fixed in 4% paraformaldehyde (PFA, Sigma)/4% Sucrose
(Sigma).

Western blot
Cortical cells were lysed with RIPA buffer. The protein
concentration of the supernatant was determined using the Bio-Rad
(Hercules, CA) protein assay reagent. Approximately 20 μg of protein
was loaded and separated in a 10% acrylamide–Bis solution (Bio-Rad)
gel. The protein was transferred onto Hybond-C Super membrane
(Amersham Biosciences, Little Chalfont, UK) and blocked with 5% skim
milk in 0.1% Tween 20 in PBS (TPBS). The membranes were incubated
with anti-PTEN (1:1000; CST; #9559S) or anti-βIII tubulin (1:2000;
Covance; #PRB-435P) in 5% BSA in TPBS overnight at 4°C. The
membranes were incubated in biotinylated secondary antibody at a
1:5,000 dilution for 1 hour at room temperature. The membranes were
incubated with HRP-conjugated antibody (Babco) before the labeled
proteins were detected using the ECL agent (Pierce, Rockford, IL),
following the supplier’s manual. The intensity of each band was
quantified using the Image J. The relative level of PTEN was expressed
as the ratio to βIII-tubulin. The quantification was the average
calculated from three biological replicates (i.e. three independent
cortical cell preparations).

Cell survival and axon regeneration quantification
To quantify regenerating axons, the crush site was identified by
tissue morphology and CTB signal intensity, and the number of CTB+
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axons that projected various distances from the lesion was recorded.
At least 4 sections were counted for each animal. To quantify RGCs,
the number of TUJ1+ cells in the ganglion cell layer of at least 4 nonconsecutive retina sections per animal was counted.

Tissue clearing
Optic nerves and brains were prepared as described above and
post-fixed overnight. Detailed description of tissue clearing is provided
in our recent manuscripts 22. Samples underwent dehydration by
incubation in increasing concentrations of tetrahydrofuran (THF,
Sigma-Aldrich) solutions. Optic nerves were incubated for 15 minutes
each in 50% THF (diluted in water v/v), 80% THF, and 100% THF.
Dehydrated optic nerves were rendered clear by incubating in BABB (a
mixture of benzyl alcohol and benzyl benzoate (Sigma-Aldrich) at a
ratio of 1:2) for 20 minutes. Adult mouse brains were gradually
dehydrated with 50% THF for 12 hours, 80% THF for 12 hours, and
100% THF for 3 × 12 hours, and cleared in BABB for 12 hours with
constant shaking before imaging.

Light Sheet Fluorescence Microscopy (LSFM) and axon
tracing
LSFM was performed as previously described 21, 49. For each
optic nerve and brain between 100 and 500 optical slices were imaged
with LSFM (LaVision) at a scan speed of 0.5–1.5 s per slice. Images
were collected at 2 to 5μm increments in the Z axis. Images, and 3D
volume rendering were prepared using Imaris software v7.6.1
(Bitplane). CTB-labeled RGC axons in the brain were traced using
Imaris Filament Tracer Module and SCN boundaries were marked with
Imaris Surface Module. Axons were identified and manually traced in
individual 2D optical slices (z stacks) and compiled to give a 3D
reconstruction.

Examination of trans-synaptic WGA labeling in iZ/WAP
mice
Transgenic mice (B6;129-Tg(CMV-Bgeo,-WGA,-ALPP)1Mgmj/J,
Jackson Laboratory; Stock number, 017524)24 that express Cre
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recombinase-inducible WGA under the direction of the CMV,
cytomegalovirus, promoter received optic nerve crush followed
immediately by AAV-EGFP or PCC injection. One weeks following
injury, AAV-Cre was injected intravitreally to induce WGA expression in
RGCs. Five weeks after AAV-Cre injection, animals were perfused and
tissues were collected for WGA immunohistochemistry.

Statistics
Data were analyzed using ANOVA and the Bonferroni withingroups comparison with additional testing using Dunnett’s test or
student’s t-test. Significant differences required P values <0.05.
Values were displayed as mean+ standard error of mean (SEM).
Sample size (up to 14/group) was chosen in accordance to several
previous studies of optic nerve regeneration1, 4, 18.

Acknowledgments
This work was supported by grants from U.S Army W81XWH-05-1-0061
(KKP), W81XWH-12-1-0319 (KKP), NEI 1R01EY022961-01 (KKP), Ziegler
Foundation (KKP), Pew Charitable Trust (KKP), Craig H. Neilsen Foundation
(KKP), and the Buoniconti Fund (KKP). We thank Imaging, and Viral Vector
Core at the Miami Project to Cure Paralysis, Dr. David Turner for SIBR vector,
Dr. Vance Lemmon and Dr. John Bixby for guidance with shRNA vector, Dr
Bryan Luikart for shPTEN plasmid.

Footnotes
Conflict of interest: Authors declare no conflict of interest.
Contributor Information
Benjamin J. Yungher, Miami Project to Cure Paralysis and Department of
Neurosurgery, University of Miami Miller School of Medicine. Mailing
address: Miami Project to Cure Paralysis, 1094 NW 14th Ter. RM 3-01,
Miami, FL, 33136. Phone: (1) 305 243 2599, Fax: (1) 305 243 3921.
Xueting Luo, Miami Project to Cure Paralysis and Department of
Neurosurgery, University of Miami Miller School of Medicine. Mailing
address: Miami Project to Cure Paralysis, 1094 NW 14th Ter. RM 3-01,
Miami, FL, 33136. Phone: (1) 305 243 2599, Fax: (1) 305 243 3921.

Gene Therapy, Vol 22, No. 10 (October 2015): pg. 811-821. DOI. This article is © Nature Publishing Group and permission
has been granted for this version to appear in e-Publications@Marquette. Nature Publishing Group does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Nature Publishing Group.

22

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Yadira Salgueiro, Miami Project to Cure Paralysis and Department of
Neurosurgery, University of Miami Miller School of Medicine. Mailing
address: Miami Project to Cure Paralysis, 1094 NW 14th Ter. RM 3-01,
Miami, FL, 33136. Phone: (1) 305 243 2599, Fax: (1) 305 243 3921.
Murray G. Blackmore, Department of Biomedical Sciences, Marquette
University. Mailing address: Department of Biomedical Sciences,
College of Health Sciences, Schroeder Complex, 429, Milwaukee, WI
53201-1881. Phone: 1 (414) 288-4532.
Kevin K. Park, Miami Project to Cure Paralysis and Department of
Neurosurgery, University of Miami Miller School of Medicine. Mailing
address: Miami Project to Cure Paralysis, 1094 NW 14th Ter. RM 4-20,
Miami, FL, 33136. Phone: (1) 305 243 2493, Fax: (1) 305 243 3921.

References
1. Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, et al. Promoting axon
regeneration in the adult CNS by modulation of the PTEN/mTOR
pathway. Science. 2008;322(5903):963–6.
2. Smith PD, Sun F, Park KK, Cai B, Wang C, Kuwako K, et al. SOCS3 deletion
promotes optic nerve regeneration in vivo. Neuron. 2009;64(5):617–
23.
3. Sun F, Park KK, Belin S, Wang D, Lu T, Chen G, et al. Sustained axon
regeneration induced by co-deletion of PTEN and SOCS3. Nature.
2011;480(7377):372–5.
4. de Lima S, Koriyama Y, Kurimoto T, Oliveira JT, Yin Y, Li Y, et al. Fulllength axon regeneration in the adult mouse optic nerve and partial
recovery of simple visual behaviors. Proc Natl Acad Sci U S A.
2012;109(23):9149–54.
5. Kotterman MA, Schaffer DV. Engineering adeno-associated viruses for
clinical gene therapy. Nat Rev Genet. 2014;15(7):445–51.
6. Alsina B, Vu T, Cohen-Cory S. Visualizing synapse formation in arborizing
optic axons in vivo: dynamics and modulation by BDNF. Nat Neurosci.
2001;4(11):1093–101.
7. Robles E, Laurell E, Baier H. The retinal projectome reveals brain-areaspecific visual representations generated by ganglion cell diversity.
Curr Biol. 2014;24(18):2085–96.
8. Chung KH, Hart CC, Al-Bassam S, Avery A, Taylor J, Patel PD, et al.
Polycistronic RNA polymerase II expression vectors for RNA
interference based on BIC/miR-155. Nucleic Acids Res.
2006;34(7):e53.
9. Zukor K, Belin S, Wang C, Keelan N, Wang X, He Z. Short Hairpin RNA
against PTEN Enhances Regenerative Growth of Corticospinal Tract
Axons after Spinal Cord Injury. J Neurosci. 2013;33(39):15350–61.
Gene Therapy, Vol 22, No. 10 (October 2015): pg. 811-821. DOI. This article is © Nature Publishing Group and permission
has been granted for this version to appear in e-Publications@Marquette. Nature Publishing Group does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Nature Publishing Group.

23

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

10. Luikart BW, Schnell E, Washburn EK, Bensen AL, Tovar KR, Westbrook
GL. Pten knockdown in vivo increases excitatory drive onto dentate
granule cells. J Neurosci. 2011;31(11):4345–54.
11. Hellstrom M, Harvey AR. Retinal ganglion cell gene therapy and visual
system repair. Curr Gene Ther. 2011;11(2):116–31.
12. Leaver SG, Cui Q, Bernard O, Harvey AR. Cooperative effects of bcl-2 and
AAV-mediated expression of CNTF on retinal ganglion cell survival and
axonal regeneration in adult transgenic mice. Eur J Neurosci.
2006;24(12):3323–32.
13. Leaver SG, Cui Q, Plant GW, Arulpragasam A, Hisheh S, Verhaagen J, et
al. AAV-mediated expression of CNTF promotes long-term survival and
regeneration of adult rat retinal ganglion cells. Gene Ther.
2006;13(18):1328–41.
14. Pernet V, Joly S, Dalkara D, Jordi N, Schwarz O, Christ F, et al. Longdistance axonal regeneration induced by CNTF gene transfer is
impaired by axonal misguidance in the injured adult optic nerve.
Neurobiol Dis. 2013;51:202–13.
15. Pernet V, Joly S, Jordi N, Dalkara D, Guzik-Kornacka A, Flannery JG, et al.
Misguidance and modulation of axonal regeneration by Stat3 and
Rho/ROCK signaling in the transparent optic nerve. Cell Death Dis.
2013;4:e734.
16. Muller A, Hauk TG, Leibinger M, Marienfeld R, Fischer D. Exogenous CNTF
stimulates axon regeneration of retinal ganglion cells partially via
endogenous CNTF. Mol Cell Neurosci. 2009;41(2):233–46.
17. Park K, Luo JM, Hisheh S, Harvey AR, Cui Q. Cellular mechanisms
associated with spontaneous and ciliary neurotrophic factor-cAMPinduced survival and axonal regeneration of adult retinal ganglion
cells. J Neurosci. 2004;24(48):10806–15.
18. Moore DL, Blackmore MG, Hu Y, Kaestner KH, Bixby JL, Lemmon VP, et al.
KLF family members regulate intrinsic axon regeneration ability.
Science. 2009;326(5950):298–301.
19. Hellstrom M, Pollett MA, Harvey AR. Post-injury delivery of rAAV2-CNTF
combined with short-term pharmacotherapy is neuroprotective and
promotes extensive axonal regeneration after optic nerve trauma. J
Neurotrauma. 2011;28(12):2475–83.
20. Hellstrom M, Harvey AR. Cyclic AMP and the regeneration of retinal
ganglion cell axons. Int J Biochem Cell Biol. 2014
21. Luo X, Yungher B, Park KK. Application of tissue clearing and light sheet
fluorescence microscopy to assess optic nerve regeneration in
unsectioned tissues. Methods Mol Biol. 2014;1162:209–17.
22. Luo X, Salgueiro Y, Beckerman SR, Lemmon VP, Tsoulfas P, Park KK.
Three-dimensional evaluation of retinal ganglion cell axon regeneration

Gene Therapy, Vol 22, No. 10 (October 2015): pg. 811-821. DOI. This article is © Nature Publishing Group and permission
has been granted for this version to appear in e-Publications@Marquette. Nature Publishing Group does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Nature Publishing Group.

24

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

23.
24.

25.

26.

27.

28.

29.

30.

31.

32.

33.

and pathfinding in whole mouse tissue after injury. Exp Neurol.
2013;247:653–62.
Pernet V, Schwab ME. Lost in the jungle: new hurdles for optic nerve axon
regeneration. Trends Neurosci. 2014;37(7):381–387.
Louis GW, Leinninger GM, Rhodes CJ, Myers MG., Jr Direct innervation
and modulation of orexin neurons by lateral hypothalamic LepRb
neurons. J Neurosci. 2010;30(34):11278–87.
Kurimoto T, Yin Y, Omura K, Gilbert HY, Kim D, Cen LP, et al. Longdistance axon regeneration in the mature optic nerve: contributions of
oncomodulin, cAMP, and pten gene deletion. J Neurosci.
2010;30(46):15654–63.
Lewandowski G, Steward O. AAVshRNA-mediated suppression of PTEN in
adult rats in combination with salmon fibrin administration enables
regenerative growth of corticospinal axons and enhances recovery of
voluntary motor function after cervical spinal cord injury. J Neurosci.
2014;34(30):9951–62.
Ohtake Y, Park D, Abdul-Muneer PM, Li H, Xu B, Sharma K, et al. The
effect of systemic PTEN antagonist peptides on axon growth and
functional recovery after spinal cord injury. Biomaterials.
2014;35(16):4610–26.
Christie KJ, Webber CA, Martinez JA, Singh B, Zochodne DW. PTEN
inhibition to facilitate intrinsic regenerative outgrowth of adult
peripheral axons. J Neurosci. 2010;30(27):9306–15.
Xu XM, Yoo MH, Carlson BA, Gladyshev VN, Hatfield DL. Simultaneous
knockdown of the expression of two genes using multiple shRNAs and
subsequent knock-in of their expression. Nat Protoc. 2009;4(9):1338–
48.
Fraser MM, Bayazitov IT, Zakharenko SS, Baker SJ. Phosphatase and
tensin homolog, deleted on chromosome 10 deficiency in brain causes
defects in synaptic structure, transmission and plasticity, and
myelination abnormalities. Neuroscience. 2008;151(2):476–88.
Hellstrom M, Muhling J, Ehlert EM, Verhaagen J, Pollett MA, Hu Y, et al.
Negative impact of rAAV2 mediated expression of SOCS3 on the
regeneration of adult retinal ganglion cell axons. Mol Cell Neurosci.
2011;46(2):507–15.
Gao Y, Deng K, Hou J, Bryson JB, Barco A, Nikulina E, et al. Activated
CREB is sufficient to overcome inhibitors in myelin and promote spinal
axon regeneration in vivo. Neuron. 2004;44(4):609–21.
Park KK, Hu Y, Muhling J, Pollett MA, Dallimore EJ, Turnley AM, et al.
Cytokine-induced SOCS expression is inhibited by cAMP analogue:
impact on regeneration in injured retina. Mol Cell Neurosci.
2009;41(3):313–24.

Gene Therapy, Vol 22, No. 10 (October 2015): pg. 811-821. DOI. This article is © Nature Publishing Group and permission
has been granted for this version to appear in e-Publications@Marquette. Nature Publishing Group does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Nature Publishing Group.

25

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

34. Wyatt C, Ebert A, Reimer MM, Rasband K, Hardy M, Chien CB, et al.
Analysis of the astray/robo2 zebrafish mutant reveals that
degenerating tracts do not provide strong guidance cues for
regenerating optic axons. J Neurosci. 2010;30(41):13838–49.
35. Osterhout JA, El-Danaf RN, Nguyen PL, Huberman AD. Birthdate and
outgrowth timing predict cellular mechanisms of axon target matching
in the developing visual pathway. Cell Rep. 2014;8(4):1006–17.
36. McFarlane S, McNeill L, Holt CE. FGF signaling and target recognition in
the developing Xenopus visual system. Neuron. 1995;15(5):1017–28.
37. Cohen-Cory S, Fraser SE. Effects of brain-derived neurotrophic factor on
optic axon branching and remodelling in vivo. Nature.
1995;378(6553):192–6.
38. Aviles-Trigueros M, Sauve Y, Lund RD, Vidal-Sanz M. Selective innervation
of retinorecipient brainstem nuclei by retinal ganglion cell axons
regenerating through peripheral nerve grafts in adult rats. J Neurosci.
2000;20(1):361–74.
39. Vidal-Sanz M, Aviles-Trigueros M, Whiteley SJ, Sauve Y, Lund RD.
Reinnervation of the pretectum in adult rats by regenerated retinal
ganglion cell axons: anatomical and functional studies. Prog Brain Res.
2002;137:443–52.
40. Wizenmann A, Bahr M. Growth characteristics of ganglion cell axons in the
developing and regenerating retino-tectal projection of the rat. Cell
Tissue Res. 1997;290(2):395–403.
41. Sauve Y, Sawai H, Rasminsky M. Topological specificity in reinnervation of
the superior colliculus by regenerated retinal ganglion cell axons in
adult hamsters. J Neurosci. 2001;21(3):951–60.
42. Carter DA, Bray GM, Aguayo AJ. Regenerated retinal ganglion cell axons
form normal numbers of boutons but fail to expand their arbors in the
superior colliculus. J Neurocytol. 1998;27(3):187–96.
43. Sauve Y, Sawai H, Rasminsky M. Functional synaptic connections made by
regenerated retinal ganglion cell axons in the superior colliculus of
adult hamsters. J Neurosci. 1995;15(1 Pt 2):665–75.
44. Carter DA, Bray GM, Aguayo AJ. Regenerated retinal ganglion cell axons
can form well-differentiated synapses in the superior colliculus of adult
hamsters. J Neurosci. 1989;9(11):4042–50.
45. Li S, He Q, Wang H, Tang X, Ho KW, Gao X, et al. Injured adult retinal
axons with Pten and Socs3 co-deletion reform active synapses with
suprachiasmatic neurons. Neurobiol Dis. 2014;73C:366–376.
46. Hattar S, Kumar M, Park A, Tong P, Tung J, Yau KW, et al. Central
projections of melanopsin-expressing retinal ganglion cells in the
mouse. J Comp Neurol. 2006;497(3):326–49.
47. Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, Juni A, et
al. Guidelines for the selection of highly effective siRNA sequences for
Gene Therapy, Vol 22, No. 10 (October 2015): pg. 811-821. DOI. This article is © Nature Publishing Group and permission
has been granted for this version to appear in e-Publications@Marquette. Nature Publishing Group does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Nature Publishing Group.

26

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

mammalian and chick RNA interference. Nucleic Acids Res.
2004;32(3):936–48.
48. Blackmore MG, Wang Z, Lerch JK, Motti D, Zhang YP, Shields CB, et al.
Kruppel-like Factor 7 engineered for transcriptional activation
promotes axon regeneration in the adult corticospinal tract. Proc Natl
Acad Sci U S A. 2012
49. Erturk A, Mauch CP, Hellal F, Forstner F, Keck T, Becker K, et al. Threedimensional imaging of the unsectioned adult spinal cord to assess
axon regeneration and glial responses after injury. Nat Med.
2012;18(1):166–71.

Gene Therapy, Vol 22, No. 10 (October 2015): pg. 811-821. DOI. This article is © Nature Publishing Group and permission
has been granted for this version to appear in e-Publications@Marquette. Nature Publishing Group does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Nature Publishing Group.

27

